|
🐜
|
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
15 auth.
Himal Lal,
A. Cunningham,
O. Godeaux,
R. Chlibek,
J. Díez-Domingo,
Shinn-Jang Hwang,
M. Levin,
J. Mcelhaney,
A. Põder,
J. Puig-Barberá,
...
T. Vesikari,
D. Watanabe,
L. Weckx,
T. Zahaf,
T. Heineman
|
10 |
2015 |
10
🐜
|
|
🐜
|
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
10 auth.
R. Prymula,
C. Siegrist,
R. Chlibek,
H. Žemličková,
M. Vacková,
J. Smetana,
...
P. Lommel,
Eva Kaliskova,
D. Borys,
L. Schuerman
|
8 |
2009 |
8
🐜
|
|
🐜
|
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
23 auth.
A. Cunningham,
T. Heineman,
Himal Lal,
O. Godeaux,
R. Chlibek,
Shinn-Jang Hwang,
J. Mcelhaney,
T. Vesikari,
C. Andrews,
W. Choi,
...
Meral Esen,
H. Ikematsu,
Martina Kovac Choma,
K. Pauksens,
S. Ravault,
B. Salaun,
T. Schwarz,
J. Smetana,
C. V. Abeele,
P. Van den Steen,
Ilse Vastiau,
L. Weckx,
M. Levin
|
7 |
2018 |
7
🐜
|
|
🐬
|
Influenza vaccination in the elderly
J. Smetana,
R. Chlibek,
Jana Shaw,
M. Špliňo,
R. Prymula
|
7 |
2018 |
7
🐬
|
|
🦁
|
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
7 auth.
R. Chlibek,
J. Bayas,
H. Collins,
María Luisa Rodríguez de la Pinta,
E. Ledent,
Johann F Mols,
...
T. Heineman
|
7 |
2013 |
7
🦁
|
|
🦁
|
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study.
10 auth.
R. Chlibek,
J. Smetana,
K. Pauksens,
L. Rombo,
J. van den Hoek,
J. Richardus,
...
Georg Plassmann,
Tino F. Schwarz,
E. Ledent,
T. Heineman
|
6 |
2014 |
6
🦁
|
|
🦁
|
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
10 auth.
R. Chlibek,
K. Pauksens,
L. Rombo,
Gini G C van Rijckevorsel,
J. Richardus,
Georg Plassmann,
...
T. Schwarz,
Grégory Catteau,
Himal Lal,
T. Heineman
|
6 |
2016 |
6
🦁
|
|
🐬
|
Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
M. van der Wielen,
P. van Damme,
R. Chlibek,
J. Smetana,
F. von Sonnenburg
|
6 |
2006 |
6
🐬
|
|
🐜
|
Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)
18 auth.
D. Zavadska,
I. Anca,
F. André,
M. Bakır,
R. Chlibek,
M. Čižman,
Inga Ivaskeviciene,
A. Mangarov,
Z. Mészner,
Marko Pokorn,
...
R. Prymula,
D. Richter,
N. Salman,
P. Šimurka,
E. Tamm,
G. Tešović,
I. Urbančíková,
V. Usonis
|
6 |
2013 |
6
🐜
|
|
🐜
|
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
15 auth.
T. Schwarz,
S. Volpe,
Grégory Catteau,
R. Chlibek,
M. David,
J. Richardus,
Himal Lal,
L. Oostvogels,
K. Pauksens,
S. Ravault,
...
L. Rombo,
G. Sonder,
J. Smetana,
T. Heineman,
A. Bastidas
|
6 |
2018 |
6
🐜
|
|
🐜
|
Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013
12 auth.
U. Heininger,
Philippe André,
R. Chlibek,
Z. Krištúfková,
K. Kutsar,
A. Mangarov,
...
Z. Mészner,
A. Nitsch-Osuch,
V. Petrović,
R. Prymula,
V. Usonis,
D. Zavadska
|
5 |
2016 |
5
🐜
|
